Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40

Nature Cell Biology

Volumn 9, Issue 3, 2007, Pages 316-323

  Haar, Emilie Vander ^a   Lee, Seong il ^a   Bandhakavi, Sricharan ^a   Griffin, Timothy J ^a   Kim, Do Hyung ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN 14 3 3; PROTEIN KINASE B; TUBERIN;

ARTICLE; CANCER; CONTROLLED STUDY; DRUG TARGETING; ELECTROSPRAY MASS SPECTROMETRY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; HAMARTOMA; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

14-3-3 PROTEINS; 3T3 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIMYCIN A; CELL LINE; CELL LINE, TUMOR; DEOXYGLUCOSE; HUMANS; IMMUNOPRECIPITATION; INSULIN; MICE; MODELS, BIOLOGICAL; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, ANTISENSE; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TRANSFECTION;

MAMMALIA;

EID: 33847397874     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1547     Document Type: Article

References (30)

1. Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K. L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nature Cell Biol. 4, 648-657 (2002).
2. Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J. & Cantley, L. C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinsitide 3-kinase/Akt pathway. Mol. Cell 10, 151-162 (2002).
3. Zhang, Y. et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nature Cell Biol. 5, 578-581 (2003).
4. Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K. & Avruch, J. Rheb binds and regulates the mTOR kinase. Curr. Biol. 15, 702-713 (2005).
5. Dong, J. & Pan, D. J. Tsc2 is not a critical target of Akt during normal Drosophila development. Genes Dev. 18, 2479-2484 (2004).
6. Hahn-Windgassen, A. et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J. Biol. Chem. 280, 32081-32089 (2005).
7. Brunn, G. J. et al. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277, 99-101 (1997).
8. Dennis, P. B. et al. Mammalian TOR, a homeostatic ATP sensor. Science 294, 1102-1105 (2001).
9. Shimji, A. F., Nghiem, P. & Schreiber, S. L. Integration of growth factor and nutrient signaling: Implications for cancer biology. Molecular Cell 12, 271-280 (2003).
10. Gao, X. et al. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nature Cell Biol. 4, 699-704 (2002).
11. Corradetti, M. N. Inoki, K., Bardeesy, N., Depinho, R. A. & Guan, K. L. Regulation of the TSC pathway by LKB1: Evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev. 18, 1533-1538 (2004).
12. Um, S. H. et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200-205 (2004).
13. Kenerson, H., Dundon, T. A. & Yeung, R. S. Effects of rapamycin in the Eker rat model of tuberous sclerosis complex. Pediatr Res. 57, 67-75 (2005).
14. Vellai, T. et al. Genetics: Influence of TOR kinase on lifespan in C. elegans. Nature 426, 620 (2003).
15. Loewith, R. et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457-468 (2002).
16. Kim, D.-H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175 (2002).
17. Kim, D.-H. et al. GβL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol. Cell 11, 895-904 (2003).
18. Hara, K. et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189 (2002).
19. Sarbassov, D. D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296-1302 (2004).
20. Sarbassov, D. D., Guertin, D. A., Ali, S. M. & Sabatini, D. M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101 (2005).
21. Jacinto, E. et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nature Cell Biol. 6, 1122-1128 (2004).
22. Eng, J., McCormack, A. L. & Yates, J. R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Mass Spectrom. 5, 976-989 (1994).
23. Keller, A., Nesvizhskii, A. I., Kolker, E. & Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392 (2002).
24. Frias, M. A. et al. mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr. Biol. 16, 1-6 (2006).
25. Jacinto, E. et al. Sin1/Mip1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 126, 1-13 (2006).
26. Kovacina, K. S. et al. Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. J. Biol. Chem. 278, 10189-10194 (2003).
27. Singh, A., Chan, J., Chern, J. J. & Choi, K.-W. Genetic interaction of lobe with its modifiers in dorsoventral patterning and growth of the Drosophila eye. Genetics 171, 169-183 (2005).
28. Tzatsos, A. & Kandror, K. V. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol. Cell. Biol. 26, 63-76 (2006).
29. Huang, B. & Porter, G. Expression of proline-rich akt-substrate PRAS40 in cell survival pathway and carcinogenesis. Acta. Pharmacol. Sin. 26, 1253-1258 (2005).
30. Saito, A. et al. Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after stroke: Relationships with nerve growth factor. J. Neurosci. 24, 1584-1593 (2004).